Alnylam Pharmaceuticals (ALNY) Q3 2014 Earnings

7AugConfirmed
Q4 2013
Q1 2014
Q2 2014
Q3 2014
-0.59
-0.52
-0.46
-0.39

Details

Expected EPS
-0.56
Actual EPS
-0.58
Surprise EPS
-0.02
Surprise Percent
+3.57%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.58 per share for Q3 2014.

0 Comments

Share your thoughts